12:05 PM EST - Acerus Pharmaceuticals Corporation : Reported its financial results for the three-month period ended June 30. Unless otherwise noted, all amounts are in U.S. dollars. The Company reported revenue of $0.6 million for the second quarter of 2021 compared with $0.2 million in the prior-year period, an increase of 219%. Gross profit was $0.5 million in the second quarter of 2021 versus a gross loss of $0.1 million in 2020. Acerus Pharmaceuticals Corporation
shares T.ASP are trading unchanged at $0.04.
